Prospective observational study investigating the impact of treatment sequence using regorafenib and FTD/TPI for metastatic colorectal cancer on overall survival

ABSTRACT: Primary outcome(s): Overall survival (OS) of sequential treatment with regorafenib-FTD/TPI

DISEASE(S): Colorectal Cancer

PROVIDER: 2655323 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR